ARIX — Arix Bioscience Balance Sheet

0.000.00%

Last trade - 00:00

FinancialsConservativeSmall CapMomentum Trap

Annual balance sheet for Arix Bioscience, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2018 December 31st	C2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	31	54.6	112	134	123
Net Total Accounts Receivable
Net Total Receivables	1.81	0.842	1.14	1.69	2.09
Prepaid Expenses
Total Other Current Assets
Total Current Assets	93.4	55.7	176	136	125
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.313	0.499	0.139	0.206	0.129
Net Intangible Assets
Long Term Investments
Total Assets	279	209	331	257	228
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9.28	6.15	2.23	1.6	1.92
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	9.28	7.11	2.5	1.72	1.93
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	270	202	328	255	226
Total Liabilities & Shareholders' Equity	279	209	331	257	228
Total Common Shares Outstanding